Sandesh Mahatme, EVP, CFO & CBO at Sarepta Therapeutics, Inc. (SRPT), sold 227,060 shares at $127.74 ($27.5M) on 2018-10-24, disclosed to the SEC on 2018-10-26.
Open-market sale of $27.5M SRPT by EVP, CFO & CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,012 | $0 | 0.0% |
| 2 | $127.74 | 107,524 | $13.7M | 50.0% |
| 3 | $127.74 | 107,524 | $13.7M | 50.0% |
| Total | $120.98 avg | 227,060 | $27.5M | 100% |
| Filing → |
| SRPT | SELL | 2019-02-01 | $8.5M | — | Filing → |
| SRPT | SELL | 2017-07-21 | $2.0M | — | Filing → |
| SRPT | SELL | 2016-10-19 | $1.5M | — | Filing → |